These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7880882

  • 21. A comparative study of the effects of clofibrate, ciprofibrate, WY-14,643, and di-(2-ethylhexyl)-phthalate on liver protein expression in mice.
    Giometti CS, Taylor J, Gemmell MA, Tollaksen SL, Lalwani ND, Reddy JK.
    Appl Theor Electrophor; 1991; 2(4-5):101-7. PubMed ID: 1782207
    [Abstract] [Full Text] [Related]

  • 22. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.
    Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y.
    J Environ Pathol Toxicol Oncol; 1992; 11(3):145-9. PubMed ID: 1625184
    [Abstract] [Full Text] [Related]

  • 23. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM, Zhou YC, Ram PA, Lee SS, Gonzalez FJ, Waxman DJ.
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [Abstract] [Full Text] [Related]

  • 24. Quantitative characterizations of proteome: dependence on the number of proteins considered.
    Randić M.
    J Proteome Res; 2006 Jul; 5(7):1575-9. PubMed ID: 16823964
    [Abstract] [Full Text] [Related]

  • 25. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, Williams G, van Gemert M.
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [Abstract] [Full Text] [Related]

  • 26. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE, Beck R, Schomaker SJ, Kenny CV.
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [Abstract] [Full Text] [Related]

  • 27. Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol).
    Yang GH, Li S, Pestka JJ.
    Toxicol Appl Pharmacol; 2000 Feb 01; 162(3):207-17. PubMed ID: 10652249
    [Abstract] [Full Text] [Related]

  • 28. Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.
    Borges T, Glauert HP, Robertson LW.
    Toxicol Appl Pharmacol; 1993 Jan 01; 118(1):8-15. PubMed ID: 8430427
    [Abstract] [Full Text] [Related]

  • 29. Hepatic protein pattern alterations following perfluorodecanoic acid exposure in rats.
    Witzmann FA, Parker DN.
    Toxicol Lett; 1991 Jun 01; 57(1):29-36. PubMed ID: 2048159
    [Abstract] [Full Text] [Related]

  • 30. Hormonal regulation of protein disulfide isomerase and chaperone synthesis in the rat exocrine pancreas.
    Hensel G, Assmann V, Kern HF.
    Eur J Cell Biol; 1994 Apr 01; 63(2):208-18. PubMed ID: 7915986
    [Abstract] [Full Text] [Related]

  • 31. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats.
    Toxic Rep Ser; 2000 Feb 01; 46():1-C7. PubMed ID: 11986676
    [Abstract] [Full Text] [Related]

  • 32. Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis.
    Cai Y, Nelson BD, Li R, Luciakova K, dePierre JW.
    Arch Biochem Biophys; 1996 Jan 01; 325(1):107-12. PubMed ID: 8554334
    [Abstract] [Full Text] [Related]

  • 33. Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice.
    Ochs JB, Baldwin LA, Leonard DA, Calabrese EJ.
    Hum Exp Toxicol; 1992 Mar 01; 11(2):83-8. PubMed ID: 1349224
    [Abstract] [Full Text] [Related]

  • 34. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation.
    Vanden Heuvel JP.
    Gen Pharmacol; 1996 Oct 01; 27(7):1123-9. PubMed ID: 8981056
    [Abstract] [Full Text] [Related]

  • 35. The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids.
    Ikeda T, Aiba K, Fukuda K, Tanaka M.
    J Biochem; 1985 Aug 01; 98(2):475-82. PubMed ID: 4066651
    [Abstract] [Full Text] [Related]

  • 36. Rat liver BiP/GRP78 is down-regulated by a peroxisome-proliferator, clofibrate.
    Motojima K, Goto S.
    FEBS Lett; 1992 Aug 17; 308(2):207-10. PubMed ID: 1499732
    [Abstract] [Full Text] [Related]

  • 37. Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects.
    Rao MS, Thorgeirsson S, Reddy MK, Lalwani ND, Evarts RE, Usman MI, Singh B, Reddy JK.
    Am J Pathol; 1986 Sep 17; 124(3):519-27. PubMed ID: 3532814
    [Abstract] [Full Text] [Related]

  • 38. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization.
    Cattley RC, Glover SE.
    Carcinogenesis; 1993 Dec 17; 14(12):2495-9. PubMed ID: 8269617
    [Abstract] [Full Text] [Related]

  • 39. Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate.
    Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y.
    Cancer Lett; 1990 Aug 17; 53(1):33-8. PubMed ID: 2397479
    [Abstract] [Full Text] [Related]

  • 40. Effects of the peroxisome proliferator perfluoro-n-decanoic acid on hepatic gluconeogenesis and glycogenesis: a 13C NMR investigation.
    Goecke CM, Jarnot BM, Reo NV.
    Chem Res Toxicol; 1994 Aug 17; 7(1):15-22. PubMed ID: 8155820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.